A 10-year-old well and asymptomatic female was referred for screening of acute right ventricular dilatation (ARVD) as she had an elder brother diagnosed with ARVD whom died of sudden cardiac death. Electrocardiography (ECG), transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR) were performed. Results of these investigations were suggestive of ARVD. Despite being a rare cardiac disease and largely unrecognised in children and young adult population, ARVD is an important cause of ventricular arrhythmias in this group of patients and is one of the causes of sudden cardiac death (SCD) in this population.
INTRODUCTION
ARVD is characterised by myocardial atrophy, fibro fatty replacement, fibrosis and ultimately thinning of the wall with chamber dilatation and aneurysm. 1 It primarily affects right ventricle (RV) which later involve biventricular dilatation. Prevalence of ARVD is approximately 1:5000, affecting men more frequently than women with a ratio of 3:1.2 The mode of inheritance in ARVD is mostly autosomal dominant. 1 The pathogenesis of ARVD has been postulated either from congenital defect, genetics and acquired factors but the evidence thus far has not been conclusive. In the absence of a clinical gold standard for the diagnosis of ARVD, in 1994, International Task Force Criteria (TFC) was established. 4 The original TFC focused on severe disease with lack of sensitivity for early stage of the disease. The recent modification of TFC included quantitative parameters which improve the diagnosis sensitivity. 4 To make a diagnosis of ARVD requires either two major criteria or one major and two minor criteria or four minor criteria (Table I) . ARVD diagnosed during adulthood has recently been shown to have a good prognosis. In contrast, ARVD in childhood has a far more uncertain prognosis and may constitute 30-50% of all sudden death in ARVD.
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CASE REPORT
A 10-year-old girl was referred for screening of ARVD as she had strong family history. She was asymptomatic and had no history of previous hospitalisations. Her brother died suddenly at the age of 15 years old having been diagnosed with ARVD. The patient underwent baseline electrocardiography (ECG), cardiac ultrasound and Cardiac Magnetic Resonance (CMR). Her ECG revealed RV strain pattern, with T inversion at V1, V2 and V3 ( Figure 1 ). The cardiac ultrasound showed grossly right ventricular (RV) dilatation and hyperechoic moderator band (Fig 2a, 2b) . During the cardiac magnetic resonance (CMR) imaging study, she developed a few episodes of non-sustained ventricular tachycardia (VT) during breath holds. CMR revealed a global decreased contractility of the RV with the RV ejection fraction measuring 24.1%. There are markedly elevated Right Ventricular End Diastolic Volume (EDV) and End Systolic Volume (ESV), while the Left Ventricular End Diastolic Volume, Left Ventricular End Systolic Volume and Left Ventricular Ejection Fraction were still preserved. The RV was dilated and wall markedly thin (Fig 2e, 2f) .
Review of her family history, revealed that her brother was diagnosed to have ARVD at the age of 14-year-old. He presented with recurrent symptoms of RV failure and Ventricular Tachycardia. ECHO (Fig 2c, 2d) and CMR (Fig 2g,  2h) showed dilatation and thin wall of Right Ventricle with minimal involvement of left ventricular dilatation. He was eventually started on antiarrhythmic agents and required regular administration of intravenous loading of amiodarone during presentation at the emergency department. While on these antiarrhythmics, ventricular arrhythmias persisted, and Implantable Cardiac Defibrillator (ICD) was implanted at the age of 15-year-old. Unfortunately, three weeks after ICD implantation, he collapsed in school and resuscitative efforts failed to revive him.
Following the strong family history and results of these imaging modalities, a diagnosis of ARVD was made on the young lady. An electrophysiology study was planned during her next follow up. She was advised to avoid exercise and any strenuous physical activities and was provided regular close interval follow-up.
DISCUSSION
The clinical presentation of ARVD has been reported to vary among patients. With reference to our patient, she is likely categorised as Concealed phase of clinical manifestation as she is still young and asymptomatic. However sudden premature cardiac death is still a risk that the patient has. Her brother had developed symptoms at the age of 14-yearold and presented with biventricular pump failure. He most likely was at phase four, with biventricular or dilated cardiomyopathy.
The diagnosis of ARVD at its early stages remains a clinical challenge. No single test can be used to establish or exclude ARVD. A keen eye at the ECG for 'epsilon waves' and a detailed echocardiography looking at the right ventricle is often useful. CMR can assist substantially in the diagnosis of anatomical abnormalities and functional disturbances, as well as detecting the presence of fat or fibrous tissue once they occur. Our patient fulfilled one major and two minor criteria from the International Task Force, ARVD classification. She had severe dilatation of Right Ventricle with reduction of RV ejection fraction in cardiac MRI, repolarisation abnormalities; T inversion in V1, V2, V3 and ARVD confirmed in a first-degree relative.
ARVD is a genetic condition, and this condition can go undetected. It is important for the family to be screened so that proper precautions such as danger of exercise and proper management can be initiated early. If screening is positive, then there is a need for close monitoring of symptoms during regular close interval follow up and early intervention if required.
Management of ARVD involves pharmacological therapy and avoidance of exercise. Antiarrhythmic drugs are used but have varying outcomes. Radiofrequency ablation in recurrent or persistent ventricular tachycardia and tachyarrhythmia is also suggested but success rates have been documented to range from 25% to 70%.4 Implantable Cardiac Defibrillator therapy also plays a big role in this case. 
